Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2021-12-09 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document text contains the header 'RNS Number : 1352V' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of market announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit the specific definitions for 10-K, ER, DIV, DIRS, etc., it falls best under the general Regulatory Filings category, which is the designated fallback for miscellaneous regulatory announcements not covered elsewhere. The code for general regulatory announcements is RNS.
2021-12-09 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading mechanics, not a comprehensive financial report or a standard regulatory filing like a 10-K or ER. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, or DLST), the most appropriate classification is the general regulatory filing fallback category, RNS.
2021-12-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 1211V'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of brief, immediate market operational announcement, especially one explicitly sourced from 'RNS, the news service of the London Stock Exchange', fits best under the general Regulatory Filings category, as it does not correspond to any of the specific financial report types (like 10-K, ER, IR, etc.). It is a regulatory notification.
2021-12-09 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security, referencing the RNS Number and the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or administrative update, distributed via the RNS system—fits best under the general Regulatory Filings category, as it does not correspond to a specific financial report (like 10-K, ER, IR) or a specific corporate action (like DIV, DIRS, CAP). It is a general regulatory announcement.
2021-12-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This clearly identifies the document as a general regulatory announcement distributed via the RNS system, which aligns with the definition for Regulatory Filings (RNS). The document is short and is an announcement of a market event, not a comprehensive financial report.
2021-12-08 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' related to trading rules, which is a general regulatory announcement rather than a specific financial report (like 10-K, ER, or IR). Given the nature of the announcement (a trading mechanism update) and the explicit reference to RNS as the distribution service, the most appropriate classification is the general Regulatory Filings category (RNS), as it is a miscellaneous regulatory notice that doesn't fit the other specific categories like DIRS, DIV, or DLST.
2021-12-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.